The PGY2 Critical Care residency program is designed to provide the resident with a solid foundation of experiences focusing on critical care pharmacotherapy. The program develops a well-rounded, knowledgeable practitioner capable of optimizing critical care drug therapy and patient outcomes.
With access to over 130 ICU beds dispersed among coronary care, medical, neurological, general surgical and cardiovascular surgical settings with clinical pharmacy specialists in each of these areas, the program is tailored to meet each resident’s needs offering a diverse range of critical care rotational experiences, research and quality improvement opportunities.
Training alongside over 50 acute care and 8 ICU clinical specialists as well as 19 other residents, the critical care resident will have ample learning and teaching opportunities including providing instruction to doctor of pharmacy students and mentoring PGY1 residents. The resident will provide an ACPE-accredited CE program and can participate in an optional teaching certificate program through the University of Houston College of Pharmacy.
Houston Methodist Hospital (HMH) is a 900+ bed tertiary teaching hospital and is an academic affiliate of Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, New York Presbyterian Hospital, and many colleges of pharmacy. HMH is consistently ranked in multiple specialties by U.S. News and World Report and recognized as the No.1 hospital in Texas and Gulf Coast. HMH is included on Forbes magazine's list of "America's Best Employers".